{
  "id": 5593588,
  "title": "This week in charts: China deals, stock flatlines and Lilly’s M&A spree",
  "url": "https://urgent.news/2026/09/04/this-week-in-charts-china-deals-stock-flatlines-and-lillys-m-a-spree",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-04T15:56:31.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/charts-biotech-deals-china-alumis-ultragenyx-stock/829635/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Deals with Chinese drugmakers are continuing at a steady pace, while two mid-cap biotechs' stock prices took a tumble this week. Meanwhile, Lilly has outpaced other pharmas in dealmaking this year.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}